Adenosine A2A receptor antagonist istradefylline for levodopa-induced complications in Parkinson's disease

To assess the efficacy and safety of adjuvant istradefylline therapy versus placebo in PD patients with levodopa-induced complications.

This is a protocol.

Health topics:

Neurology > Movement disorders > Parkinson's disease

Published:

14 March 2012

Authors:

Xiao Y, Gan L, Wang J

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Xiao Y, Gan L, Wang J. Adenosine A2A receptor antagonist istradefylline for levodopa-induced complications in Parkinson's disease. Cochrane Database of Systematic Reviews 2012, Issue 3. Art. No.: CD009709. DOI: 10.1002/14651858.CD009709